Strides Arcolab’s Q2 consolidated net decline by 97%

27 Oct 2015 Evaluate

Strides Arcolab has reported results for second quarter ended September 30, 2015.

The company has reported 97.25% fall in its net profit at Rs 9.32 crore for the quarter ended September 30, 2015 as compared to Rs 338.47 crore for the same quarter in the previous year. However, the company’s total income has increased by 16.83% to Rs 285.12 crore for the quarter under review from Rs 244.04 crore for the corresponding quarter of the previous year.

On the consolidated basis, the company has reported 97.62% fall in its net profit after taxes, Minority Interest and Share of Profit/(Loss) of Associates of Rs 18.98 crore for the quarter ended September 30, 2015 as compared to Rs 797.83 crore for the same quarter in the previous year. However, total income of the company has increased by 31.37% at Rs 390.59 crore for quarter under review as compared to Rs 297.32 crore for the quarter ended September 30, 2014.   

Strides Pharma Scien Share Price

862.85 -15.80 (-1.80%)
08-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1795.30
Dr. Reddys Lab 1267.15
Cipla 1497.45
Zydus Lifesciences 924.35
Lupin 2071.35
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×